Company Filing History:
2 out of 168 
2 out of 11 
1 out of 3 Years Active: 2015-2019
Title: Inventor David Gally: Pioneering Immunogenic Compositions in Edinburgh
Introduction
David Gally is a prominent inventor based in Edinburgh, GB. He has made significant contributions to the field of immunology, particularly with his innovative work focused on immunogenic compositions. With a total of two patents to his name, Gally's research is directed at enhancing the understanding and treatment of O157:H7 infections.
Latest Patents
David Gally's latest patents reveal groundbreaking advancements in immunogenic technology. His work includes the development of immunogenic compositions containing H7 flagella and methods for their use. These compositions not only induce an immune response in animals but also provide critical protection against colonization by O157:H7. By preventing or reducing attachment of O157:H7 to cellular structures in the host, Gally's inventions promise to lessen the impact of this harmful bacteria.
Career Highlights
Throughout his career, David Gally has been associated with esteemed organizations such as the University of Edinburgh and Moredun Research Institute. His ongoing research has positioned him at the forefront of immunological studies, contributing valuable insights that may influence future vaccine developments and public health strategies.
Collaborations
In his journey as an inventor, Gally has collaborated with notable individuals, including Tom Nathan McNeilly and David George Emslie Smith. These partnerships have likely enriched his research and broadening the scope of innovation within the field.
Conclusion
David Gally stands out as a significant inventor in the realm of immunogenic research. His patents reflect a commitment to advancing medical science and offer hope for better preventive measures against O157:H7 infections. As he continues to push the boundaries of innovation, Gally's work is poised to make a lasting impact in the field of immunology.